Our results also indicate that the reverse effects of ZEB1 in KRASG12D CRC cells but not in BRAFV600E CRC cells are not related to a differential regulation of other transcription factors known to induce an EMT (e.g., ZEB2, SNAI1, TWIST1). The gene discussed is ZEB2; the disease is colorectal carcinoma.